Banyu Pharmaceutical Co. Ltd

Hiroyuki Kishino

Akio Kanatani

Minoru Moriya

Hidekazu Takahashi

Shunji Sakuraba

Takehiro Fukami

Toshihiro Sakamoto

Katsumasa Nonoshita

Takeshi Sagara

Makoto Jitsuoka

Takao Suzuki

Minoru Kameda

The present invention provides an imidazopyridine compound represented by formula (I), wherein Rand Reach independently represent a Calkyl group et al; Rand Reach independently represent a hydrogen atom, a methyl et al; Aris a divalent substituent representing a monocyclic or bicyclic, 3- to 8-membered aromatic or aliphatic heterocyclic group et al; Arrepresents an aromatic carbocyclic group, or an aromatic heterocyclic group; W represents &#x2014;(CH)et al, and m indicates an integer of from 0 to 10. This compound acts as a melanin concentrating hormone receptor antagonist, and is useful as treating agents for obesity.

Imidazopyridine compound

The invention provides imidazopyridine derivatives represented by the general formula [I] [in which Rand Rmay be the same or different and stand for Calkyl or the like, Rand Rstand for hydrogen atom, methyl group or the like, W stands for mono- or bi-cyclic 3- to 8-membered aromatic or aliphatic heterocycle or the like, and Ar stands for optionally substituted aromatic heterocycle or the like]. These compounds act as melanin-concentrating hormone receptor antagonist and are useful as medicines for central nervous system disorders, cardiovascular system disorders and metabolic disorders.

Imidazopyridine derivatives

Spiro compounds

Growing community of inventors

Tsukubamirai, Japan

Hiroyuki Kishino